25th September 2017
- 0 comments
Maven Capital Partners is leading an investment in ADC Biotechnology to support the construction of a dedicated pharmaceutical manufacturing facility at a site in Deeside, North Wales, creating 50 new scientific jobs.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage